Bionexus Gene Lab Stock Company Profile

Description

BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management, primarily focusing on cardiovascular, diabetes, and cancer-related indications primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of cancers comprising nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon; bowel diseases, such as colitis and Crohn; and osteoarthritis. The company also wholesales industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Asia Pacific region. It markets its blood based genomic screening process to health care providers, such as doctors, laboratories, and hospitals. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.